Alessio Branchini Shares His Latest Work on Albumin-Fused Factor IX Variants and Thanks The Whole Team
Alessio Branchini, Associate Professor of Molecular Biology at University of Ferrara, shared on LinkedIn:
”Very proud to announce that our paper is published!
Great and hard, but exciting, work on the characterization and biodistribution of engineered albumin-fused factor IX variants with tailored biinding to extravascular collagen.
Wonderful collaborations involving our group at the University of Ferrara, the team at the University of Oslo and the San Raffaele Hospital.
From the University of Ferrara side, excellent work by Maria Francesca Testa, Rebecca Tarantino and Mascia Benedusi.
Very thankful to Jan Terje Andersen, Kristin Hovden Aaen and Jeannette Nilsen (University of Oslo for the wonderful and ongoing collaboration (10 years!), to Alessio Cantore and Cesare Canepari (Ospedale San Raffaele) for their extremely valuable contribution, as well as to all collaborators.
Together we made this story possible.
Of course, a particular thank you to my (and our) mentors Francesco Bernardi and Mirko Pinotti at the University of Ferrara.
Last but not least, I am really grateful to the Access to Insight Basic Research Grant program by Novo Nordisk.
Press releases on Eurekalert and on the news site of University of Ferrara.”
Read the full article in Nature Communications.
Article: Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties
Authors: Kristin Hovden Aaen, Maria Francesca Testa, Jeannette Nilsen, Rebecca Tarantino, Cesare Canepari, Mascia Benedusi, Sopisa Benjakul, Mari Nyquist-Andersen, Marie Leangen Herigstad, Alessio Cantore, Giuseppe Valacchi, Inger Sandlie, Francesco Bernardi, Mirko Pinotti, Alessio Branchini, Jan Terje Andersen
Stay updated on all scientific advances with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy